Allergic Reaction Clinical Trial
Official title:
Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts. Determination of the in Vivo Allergenic Potency in Histamine Equivalent Units (HEP).
The objective of this study is to determine the biological activity of Juniperus oxycedrus and Cupressus arizonica. allergen extracts in histamine equivalent prick (HEP) units, in order to be used as in-house reference preparation (IHRP).
The trial will consist of a single visit, in which the following procedures will be carried out: - Demographic data. - Clinical history. - Inclusion/exclusion criteria. - Physical examination. - Pregnancy test. - Performance of prick-tests (3 concentrations of Juniperus oxycedrus and Cupressus arizonica allergenic extract, positive control and negative control). - Obtaining a blood sample from the patient to create a pool of sera for the "in vitro" standardization of the allergenic extract. - Each serum sample will be stored in a tube labeled with the subject number and frozen. These serum samples will remain in the freezer until the end of the study. When the study is completed, they will be transported to the laboratory, where all sera will be pooled. This "pool" of sera will be used to perform the complementary in vitro tests necessary to standardize and characterize this extract and produce its corresponding IHRP (In-house reference preparation), as indicated by the Royal Spanish Pharmacopoeia and the European Pharmacopoeia. In addition, it will be used in the in vitro analyses necessary for the standardization of new batches of this allergenic extract. Once the pool has been formed, the tubes containing the original serum samples are destroyed. - Evaluation of adverse events. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04058743 -
Nickel Sensitivity
|
N/A | |
| Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
| Not yet recruiting |
NCT06065137 -
Standardised Drug Provocation Testing in Perioperative Hypersensitivity
|
Phase 4 | |
| Active, not recruiting |
NCT05605795 -
Investigation of Cross-allergies Between Cefazolin and Amoxicillin With Skin Tests and Provocation Test
|
||
| Completed |
NCT04510376 -
Allergy Potential of Omeza Collagen Matrix in Human Subjects Using the Skin Prick Method
|
N/A | |
| Completed |
NCT05185479 -
Analysis of Adverse Events in Anesthesia Using Artificial Intelligence
|
||
| Recruiting |
NCT05185362 -
Epidemiology of Pecan Nut Allergy
|
||
| Completed |
NCT03489694 -
Repeatability and Reproducibility of Skin Test Endpoint Titration
|
||
| Completed |
NCT03525496 -
Interest of Challenge Tests for Diagnosis of Immediate Hypersensitivity Against Iodinated Contrast Agents
|
||
| Completed |
NCT03942692 -
What is the Allergy Follow-up for Children After Anaphylactic Reaction? AFCAR : Allergy Follow-up for Children After Anaphylactic Reaction
|
||
| Enrolling by invitation |
NCT05670756 -
Preoperative Survey to Evaluate Patient Allergy
|
||
| Recruiting |
NCT05462444 -
Development of Personalized Balanced Nutrition Concept Through an IT Platform
|
||
| Not yet recruiting |
NCT05284253 -
Is There an Allergy to Pure Metallic Gold Microparticles?
|
N/A | |
| Completed |
NCT03157505 -
Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis
|
Phase 3 | |
| Completed |
NCT01436617 -
Assessing the Value of a Dosage of Anti-cetuximab in the Therapeutic Management of Patients With Colon Cancer or Upper Aero-digestive Tract and Candidates for Treatment With Cetuximab
|
Phase 2 | |
| Not yet recruiting |
NCT05532566 -
Quercus Ilex and Quercus Robur Allergen Extracts Standardisation
|
N/A | |
| Recruiting |
NCT06011603 -
Prineo Sensitivity Dressing Study
|
Phase 4 | |
| Completed |
NCT04761822 -
COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations
|
Phase 2 | |
| Recruiting |
NCT05367531 -
Assessment of Injectable Medication Platforms
|
N/A |